Wegovy Pill (Oral Semaglutide Tablet)

starstarstarstarstar
Feefo

Images for illustrative purposes only

The Wegovy pill is a once-daily tablet containing semaglutide that helps you lose weight by reducing your appetite. It is the first GLP-1 receptor agonist tablet licensed for weight management in the UK, giving you a needle-free alternative to the weekly Wegovy injection.

Availability: In stock and available to order. The Wegovy pill was approved by the MHRA on 11 June 2026 and can now be prescribed privately in the UK. As a prescription-only medicine, it is only supplied after a clinician has assessed that it is suitable and safe for you.

  • Needle-free, once-daily oral tablet
  • Mimics natural hunger hormones to increase feelings of fullness
  • Clinically proven to reduce body weight by an average of 13.6%
  • Prescribed by UK-registered clinicians with discreet delivery
In Stock
Best Seller
Discreet Packaging
Prescription included
Quick & Easy
Free shipping over £50
Save 10% with Plus
Subscribe and Save with UK Meds Plus
£99.99 
Save 10% with Plus
Subscribe and Save with UK Meds Plus
You will need to answer a few questions about your health before completing purchase of this item.

More information

Wegovy for Weight Loss: A Doctor’s Explanation

Wegovy is a branded version of semaglutide, a GLP-1 receptor agonist used to treat obesity and support weight loss. Until now, it was only available as a weekly injection, but the same medicine can now be prescribed as a once-daily tablet. It works alongside a reduced-calorie diet and more physical activity, rather than in place of them.

Dr Shane Charles (MBBS, MRCS, PgDip SEM) - GMC Number 8085739

GP and surgeon Dr Shane Charles (MBBS, MRCS, PgDip SEM) explains how Wegovy works:

"Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist that has shown efficacy in promoting weight loss and in the management of type 2 diabetes mellitus (T2DM)."

If you think this treatment may be suitable for you, you can begin an online consultation. A registered prescriber will review your information.

Video: The Wegovy Pill Explained by a GP

In the video below Dr Nighat Arif provides an overview of the most important information about the Wegovy tablet in an interview on This Morning on 6th July 2026.

How does the Wegovy pill work?

The Wegovy pill works by mimicking a natural gut hormone called GLP-1 (glucagon-like peptide-1), which your body releases after you eat. Its active ingredient, semaglutide, acts on the appetite centres in your brain to help you feel fuller for longer, reduce hunger and lower food cravings. It also slows down stomach emptying, so you feel satisfied with smaller portions. Eating less over time, alongside a reduced-calorie diet and more activity, is what leads to weight loss.

Because semaglutide is a peptide, the stomach would normally break it down before it could be absorbed. To get around this, the tablet includes an absorption enhancer called SNAC (sodium N-(8-(2-hydroxybenzoyl)amino)caprylate), which protects the semaglutide and helps a small, steady amount pass through the stomach lining. This is why the tablet has to be taken in a very specific way, which we explain below, and why oral doses are higher than injectable ones.

How much weight can you lose on the Wegovy pill?

In the OASIS 4 clinical trial, adults taking the 25mg Wegovy tablet lost an average of 13.6% of their body weight over 64 weeks, compared with 2.2% for those taking a placebo. These results were achieved alongside diet and lifestyle changes. This is a real-world result, measured across everyone in the trial, regardless of how closely they followed the strict dosing routine.

Among participants who took the tablet exactly as prescribed, average weight loss reached up to 16.6% (compared with 2.7% on placebo), and around 30% of people on the tablet lost 20% or more of their body weight. In short, the Wegovy pill only works to its full potential when the fasting and timing rules are followed, so taking it correctly makes a real difference to your results. These results build on the earlier OASIS 1 trial, which first showed that oral semaglutide could produce significant weight loss in adults with obesity.

Trial averages are not a guarantee of your own results. Weight loss varies from person to person depending on your dose, how consistently you take it, any side effects, how long you stay on treatment, your starting health and your lifestyle. Treatment suitability is always confirmed by a clinician.

Source: Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). N Engl J Med. 2025;393(11):1077-1087.

Wegovy Pill Dosage and Titration

The Wegovy pill is started at a low dose and increased gradually to help your body adjust and reduce side effects. You stay on each dose for at least one month before moving up. The maintenance dose is 25mg once daily.

Wegovy pill dosing schedule showing 1.5 mg on days 1 to 30, 4 mg on days 31 to 60, 9 mg on days 61 to 90, and 25 mg from day 91 onwards
Dose (Once Daily)WhenNotesAvailability
1.5mgDays 1 to 30 (month one)Starting doseIn Stock
4mgDays 31 to 60 (month two)TitrationIn Stock
9mgDays 61 to 90 (month three)TitrationExpected mid-July
25mgDay 91 onwardsMaintenance doseExpected mid-July

Dose increases are approved by your prescriber, who will check that you are on the right dose for you. You may stay on a lower dose for longer if a higher dose causes side effects, or if you are happy with your weight loss without moving up.

Missed a dose? If you forget to take your tablet, skip the missed dose and take your next one at the usual time the following morning. Do not take two tablets on the same day to make up for a missed one.

Wegovy Oral Tablet Pricing

Wegovy pill pricing is determined by your daily tablet dose. Prices start from £99.99, and your treatment always requires a clinician assessment before it can be supplied. You can see the cost for each dose below.

DoseStagePrice
1.5mgStarter dose£99.99
4mgTitration£104.99
9mgTitrationTBC
25mgMaintenanceTBC

Prices shown are for the oral tablet pathway. Treatment requires a clinician assessment before supply, so ordering starts with a consultation rather than a direct purchase.

How do you take the Wegovy pill?

You take one Wegovy tablet once a day, first thing in the morning, on an empty stomach. The timing rules matter because food, drink and other medicines all reduce how much semaglutide your body can absorb. To get the full benefit:

  • Take it as soon as you wake up, after fasting overnight for at least 8 hours.
  • Swallow the tablet whole with a small sip of plain water, no more than 120ml. Do not split, crush or chew it.
  • Wait at least 30 minutes before you eat, drink anything else, or take any other tablets.
  • Do not take it with tea, coffee or any other drink, as this can stop it working properly.

"Taking the Wegovy pill on an empty stomach, then waiting before you eat or drink, is exactly what lets the medicine be absorbed. Take it with food or coffee, and far less gets into your system, so the results suffer. Building it into your wake-up routine helps it quickly become second nature."

UK Meds Clinical Team

Can I switch to the Wegovy pill from an injection?

Yes, switching to the Wegovy pill from a weight loss injection is possible, and your prescriber will confirm the right pill dose and timing for you. The established equivalence is that the 2.4mg Wegovy injection matches the 25mg tablet. You would usually start the tablet one week after your last injection, but your prescriber will confirm this. Any switch is always done under clinical supervision.

Switching From Wegovy Injections to Wegovy Pills

Use the table below as a general guide only. Your prescriber sets your exact starting dose based on your current dose and how you have tolerated treatment.

Current Wegovy injection doseWegovy pill dose you may switch to (prescriber confirmed)
0.25mg4mg
0.5mg4mg
1mg9mg
1.7mg9mg
2.4mg25mg

Can I switch from Mounjaro to Wegovy pills?

Switching from Mounjaro (tirzepatide) to the Wegovy pill is also possible under your prescriber's guidance, and the right dose depends on your current Mounjaro dose and any side effects you have experienced. The table below is an example of what a conversion could look like.

Current Mounjaro injection doseWegovy pill dose you may switch to (prescriber confirmed)
2.5mg4mg
5mg4mg
7.5mg9mg
10mg9mg
12.5mg9mg
15mg25mg

Wegovy Pill vs Wegovy Injection

Wegovy pills and injections contain the same active ingredient, semaglutide, and produce broadly similar weight loss, so the main difference is your daily routine rather than effectiveness. The pill avoids needles but must be taken daily alongside adherence to strict fasting rules, while the injection is taken once weekly with no food restrictions. The table below compares them using each product's own clinical trial, keeping the figures on a like-for-like real-world basis.

 Wegovy PillWegovy InjectionWegovy Higher-Dose Injection
Dose25mg daily2.4mg weekly7.2mg weekly
TrialOASIS 4STEP 1STEP UP
Average weight lossAround 13.6%Around 14.9%Around 18.7%
Trial length64 weeks68 weeks72 weeks
How is it taken?Once daily, on an empty stomachOnce weekly, any timeOnce weekly, any time

The gap between the pill and the standard injection is small and unlikely to be meaningful for most people. The higher-dose injection is an option for those who do not reach their goals on the standard dose. Which is right for you comes down to whether you prefer a daily tablet with a fasting routine or a weekly injection.

Wegovy Pill vs Mounjaro

Mounjaro (tirzepatide) tends to produce greater average weight loss than semaglutide in trials because it targets two gut hormone receptors (GLP-1 and GIP) rather than one. The Wegovy pill offers a needle-free, semaglutide-based option instead. The figures below come from each drug's own trials, so treat them as a general guide rather than a direct comparison. The one head-to-head trial, SURMOUNT-5, compared tirzepatide against the semaglutide injection and found tirzepatide produced greater weight loss (20.2% versus 13.7% over 72 weeks).

 Wegovy pillMounjaro
Active ingredientSemaglutideTirzepatide
Average weight lossAround 13.6% over 64 weeks (OASIS 4)Around 20% over 72 weeks (SURMOUNT-5)
FormatDaily tablet, fasting routine requiredWeekly injection, no food restrictions

Are there other weight loss tablets?

There are other weight loss tablets available, but they are not GLP-1 medicines. The Wegovy pill is the first GLP-1 tablet licensed for weight loss, while oral semaglutide, sold as Rybelsus, is licensed for type 2 diabetes only, not weight loss. Other weight loss tablets work in different ways, such as blocking the absorption of dietary fat or acting on the brain's appetite and reward centres. The table below compares the Wegovy pill with the main alternatives available in the UK.

TreatmentWegovy PillOrlistatXenicalAlliMysimba
Active ingredientSemaglutideOrlistatOrlistatOrlistatNaltrexone and bupropion
How oftenOnce dailyUp to 3 times a dayUp to 3 times a dayUp to 3 times a dayTwice a day
How it worksReduces appetite and slows digestionBlocks fat absorptionBlocks fat absorptionBlocks fat absorptionActs on appetite
Prescription?YesYesYesNo (pharmacy medicine)Yes

Is the Wegovy pill the same as Rybelsus?

No. Both the Wegovy pill and Rybelsus are oral semaglutide tablets, so they contain the same active ingredient, but they are licensed for different reasons and use different doses. Rybelsus (3mg, 7mg and 14mg) is licensed to help manage type 2 diabetes. The Wegovy pill (up to 25mg) is the version specifically licensed for weight management. So if you are searching for oral semaglutide for weight loss, the Wegovy tablet is the licensed option, not Rybelsus.

Wegovy Pill Side Effects

Like all medicines, the Wegovy pill can cause side effects, although not everyone gets them. Most are related to digestion and tend to be mild and to ease as your body adjusts, especially while your dose is being increased. The list below is a general guide.

Common Side Effects

  • Feeling sick (nausea)
  • Diarrhoea
  • Constipation
  • Being sick (vomiting)
  • Indigestion, bloating or wind
  • Tiredness and headache

Less Common but More Serious

Speak to your prescriber or a pharmacist if side effects are severe or do not settle. Semaglutide has been linked to inflammation of the pancreas (pancreatitis) and to gallbladder problems, although this is rare. A 2024 study in JAMA Ophthalmology also reported a possible link to a rare eye condition that affects the optic nerve (NAION). Additionally, it has been listed as a very rare side effect in the official patient information leaflet. Tell a doctor promptly if you notice a sudden change in your vision.

When To Get Urgent Help

Get urgent medical help if you have severe or ongoing tummy pain that may spread to your back, a severe allergic reaction (such as swelling of the face, lips or throat, or difficulty breathing), or any symptom that worries you. Contact your prescriber, call NHS 111, or in an emergency call 999 or go straight to A&E. You can also report side effects through the MHRA Yellow Card scheme.

Monalisa Kapinga - Pharmacist and Clinical Safety Officer - GPhC Number 2232744

Independent pharmacist Monalisa Kapinga explains the most common side effects:

"Wegovy can cause digestive effects like nausea, vomiting, diarrhoea and constipation, which usually improve as your body adjusts. Eating smaller, low-fat meals and staying hydrated can help. Tiredness and dizziness are also common early on. Seek urgent medical help if you experience severe abdominal pain (pancreatitis) or signs of an allergic reaction."

Who can take the Wegovy pill?

The Wegovy pill is licensed for adults living with obesity or who are overweight with a weight-related health condition, alongside a reduced-calorie diet and more physical activity. As a general guide, you may be suitable if you have:

  • A body mass index (BMI) of 30 or above, or
  • A BMI between 27 and 30 with at least one weight-related condition, such as high blood pressure, high cholesterol or type 2 diabetes.

If you are from a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background, weight-related health risks can occur at a lower BMI, so a lower threshold may apply. Your prescriber will take this into account when they assess your eligibility.

Who Should Not Take the Wegovy Pill

The Wegovy pill is not suitable for everyone. You should not take it if you are pregnant, trying to become pregnant or breastfeeding, and it is generally avoided if you have a personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or a history of pancreatitis.

It is not recommended if you have severe kidney or liver problems, and extra care is needed if you have diabetic eye disease (retinopathy). Your prescriber will review your full medical history during your consultation to check that it is safe for you.

How To Order the Wegovy Pill From UK Meds

You can order the Wegovy pill from UK Meds by completing a short online consultation, which is reviewed by a UK-registered independent prescriber. UK Meds is an online prescription service, so if treatment is suitable and safe for you, your prescription is dispensed and posted discreetly to your door by our GPhC-registered partner pharmacy, Medicines2Patient (GPhC registration 9011487). Ordering works in three simple steps: choose your treatment, complete your consultation, and receive your delivery.

Delivery Options

We deliver your Wegovy pills directly to your door in secure, discreet packaging. Standard delivery is free on orders over £49.99, and next-day delivery is available. Keep your tablets in their original blister packs until you are ready to take them, to protect them from light and moisture.

New to weight loss treatment? Read our beginner's guide to the Wegovy pill for a detailed overview. You should also read the Patient Information Leaflet (PIL) before starting treatment, which lists the full information on how to use your medicine safely.

Wegovy Pill: Frequently Asked Questions

Can you buy the Wegovy pill in the UK?

Yes. The Wegovy pill was approved by the MHRA on the 11th of June 2026 and can now be prescribed privately in the UK. It is in stock and available to order from UK Meds after a short online consultation with a UK-registered prescriber. As a prescription-only medicine, it is only supplied once a clinician confirms it is suitable for you.

How much does the Wegovy pill cost?

Wegovy pill prices start from £99.99 and are set by your daily tablet dose. The 1.5mg starter dose costs £99.99 and the 4mg dose costs £104.99, with pricing for the 9mg and 25mg doses to be confirmed. Treatment requires a clinician assessment before it can be supplied.

How much weight can you lose on the Wegovy pill?

In the OASIS 4 trial, adults taking the 25mg tablet lost an average of 13.6% of their body weight over 64 weeks, compared with 2.2% on placebo. Among those who took it exactly as prescribed, average weight loss reached up to 16.6%.

How do you take the Wegovy pill?

Take one tablet once a day, first thing in the morning, after fasting overnight for at least 8 hours. Swallow it whole with a small sip of plain water (no more than 120ml), then wait at least 30 minutes before eating, drinking or taking other medicines. Do not take it with tea or coffee.

Can you drink coffee after taking the Wegovy pill?

Not straight away. Wait at least 30 minutes after taking your tablet before drinking coffee, tea or anything other than the small sip of water used to swallow it. Drinking too soon can reduce how well the medicine is absorbed.

What happens if you miss a dose of the Wegovy pill?

Skip the missed dose and take your next tablet at the usual time the following morning. Do not take two tablets on the same day to make up for a missed one.

Can I switch from Wegovy injections to the pill?

Yes, and your prescriber confirms your exact dose. The established equivalence is that the 2.4mg injection matches the 25mg tablet, and you usually start the tablet one week after your last injection. Any switch should be done under clinical supervision.

Is the Wegovy pill safe?

The Wegovy pill has met the MHRA's standards for safety, quality and effectiveness and is only supplied after a prescriber has reviewed your medical history. Most side effects are mild and digestive. There are some situations where it is not suitable, which your prescriber will discuss with you.

Is the Wegovy pill the same as Rybelsus?

Both are oral semaglutide, but they are licensed differently. Rybelsus (3mg to 14mg) is for type 2 diabetes, while the Wegovy pill (up to 25mg) is the version licensed for weight management.

Is the Wegovy pill available on the NHS?

Not currently. MHRA approval means the pill can be prescribed privately, but NHS use depends on a separate assessment by NICE, which has not yet been completed. Access is private at first.

Wegovy pill or injection: which is better?

Neither is simply better. Both use semaglutide and produce broadly similar weight loss. The pill avoids needles but must be taken daily with strict fasting rules, while the injection is once weekly. The best choice depends on your routine and preferences.

Final Thoughts From Our Clinical Team

"The arrival of an oral GLP-1 is a genuine step forward, because for some people the needle has been the one thing holding them back from treatment that could help. The Wegovy pill can be an effective option if you are eligible and you are willing to stick to the daily routine, since the fasting and timing rules are what make it work. It is not a shortcut, and it works best as part of a wider approach that includes changes to your diet and activity. Results vary from person to person, side effects are usually manageable, and there are some people for whom it is not the right choice. That is exactly why the consultation matters. If you are considering it, complete an online consultation with us, be open about your medical history, and our prescribers will help you find the most suitable option, whether that is the pill, an injection, or a different approach altogether."

UK Meds Clinical Team

Medical disclaimer: This page is for general information and does not replace advice from a qualified healthcare professional. It should not be used to diagnose or treat any condition. The Wegovy pill is a prescription-only medicine and is only supplied after a clinician has confirmed it is suitable for you. Always read the Patient Information Leaflet, and speak to your prescriber or a pharmacist if you have any questions about your treatment.

Our commitment to content accuracy

Our content is reviewed by qualified clinicians to make sure it is accurate, balanced and up to date. We reference recognised sources such as the manufacturer's Summary of Product Characteristics, the MHRA and peer-reviewed clinical trials, and we update our pages as new information becomes available. If you spot anything that needs correcting, please let us know. For further information please read our editorial policy and content policy.

References

  1. Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). New England Journal of Medicine. 2025;393(11):1077-1087. nejm.org
  2. Knop FK, Aroda VR, do Vale RD, et al. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 2023;402(10403):705-719. thelancet.com
  3. Buckley ST, Baekdal TA, Vegge A, et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018;10(467):eaar7047. science.org
  4. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002. nejm.org
  5. Wharton S, Freitas P, Hjelmesaeth J, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. The Lancet Diabetes & Endocrinology. 2025;13(11):949-963. pubmed.ncbi.nlm.nih.gov
  6. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine. 2025;393(1):26-36. nejm.org
  7. Hathaway JT, Shah MP, Hathaway DB, et al. Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide. JAMA Ophthalmology. 2024;142(8):732-739. jamanetwork.com
  8. Medicines and Healthcare products Regulatory Agency. First GLP-1 tablet for weight loss approved in the UK. 11 June 2026. gov.uk
  9. Summary of Product Characteristics, oral semaglutide (Wegovy) tablets. Electronic medicines compendium (emc).
  10. Summary of Product Characteristics, Wegovy (semaglutide) injection. Electronic medicines compendium (emc).

Author

Content author

Scott Weaver

Medical Content Writer • Bachelor of Arts Degree

Scott is an experienced, skilled medical content writer dedicated to creating helpful and accessible health and wellbeing content for UK Meds.

Read more

Here to help you

Our Customer Service is available Monday to Friday 9am - 5pm. If you need urgent assistance, do not use this service. Call 111, or in an emergency call 999. Visit our help section